Decorin accelerates the liver regeneration after partial hepatectomy in fibrotic mice

Chinese Medical Journal

Volumn 127, Issue 14, 2014, Pages 2679-2685

  Ma, Rui ^a   Chen, Jiang ^a   Li, Zhe Yong ^a   Tang, Jia Cheng ^a   Wang, Yi Fan ^a   Cai, Xiu Jun ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Decorin; Hepatectomy; Liver fibrosis; Regeneration; Transforming growth factors

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; COLLAGEN; DECORIN; GLUCOSYLTRANSFERASE; MESSENGER RNA; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL ACTIVATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER INJURY; LIVER REGENERATION; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; STELLATE CELL; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; LIVER CIRRHOSIS; LIVER RESECTION; METABOLISM;

ANIMALS; ANTIGENS, CD31; DECORIN; HEPATECTOMY; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER REGENERATION; MALE; MICE; MICE, INBRED BALB C;

EID: 84904437915     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20131361     Document Type: Article

References (33)

1. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836-847.
2. Michalopoulos GK. Liver regeneration: alternative epithelial pathways. Int J Biochem Cell Biol 2011; 43: 173-179.
3. Yang W, Koti R, Glantzounis G, Davidson BR, Seifalian AM. Arterialization of the portal vein improves hepatic microcirculation and tissue oxygenation in experimental cirrhosis. Br J Surg 2003; 90: 1232-1239.
4. Clemens MG, Zhang JX. Regulation of sinusoidal perfusion: in vivo methodology and control by endothelins. Semin Liver Dis 1999; 19: 383-396.
5. Oda M, Han JY, Yokomori H. Local regulators of hepatic sinusoidal microcirculation: recent advances. Clin Hemorheol Microcirc 2000; 23: 85-94.
6. McCuskey RS. Morphological mechanisms for regulating blood fow through hepatic sinusoids. Liver 2000; 20: 3-7.
7. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996; 2: 418-423.
8. Zhang Z, Li XJ, Liu Y, Zhang X, Li YY, Xu WS. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts. Burns 2007; 33: 634-641.
9. Wang T, Zhou XT, Yu Y, Zhu JY, Dai JH, Qu XM, et al. Inhibition of corneal fibrosis by Smad7 in rats after photorefractive keratectomy. Chin Med J 2013; 126: 1445-1450.
10. Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP, Schirmacher P, et al. TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 1999; 276: 1059-1068.
11. Dudas J, Kovalszky I, Gallai M, Nagy JO, Schaff Z, Knittel T, et al. Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis. Am J Clin Pathol 2001; 115: 725-735.
12. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
13. Iozzo RV. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 1999; 274: 18843-18846.
14. Ameye L, Young MF. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 2002; 12: 107-116.
15. Schaefer L, Iozzo RV. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 2008; 283: 21305-21309.
16. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990; 346: 281-284.
17. Sun CK, Chen CH, Kao YH, Yuen CM, Sheu JJ, Lee FY, et al. Bone marrow cells reduce fibrogenesis and enhance regeneration in fibrotic rat liver. J Surg Res 2011; 169: 8.
18. Park SY, Lee JY, Tak WY, Kweon YO, Lee MS. Erythropoietin decreases carbon tetrachloride-induced hepatic fibrosis by inhibiting transforming growth factor-beta. Chin Med J 2012; 125: 3098-3103.
19. Mitchell C, Willenbring H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc 2008; 3: 1167-1170.
20. Matsuo R, Nakano Y, Ohkohchi N. Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy. Ann Surg 2011; 253: 759-763.
21. Bockhorn M, Goralski M, Prokofev D, Dammann P, Grunewald P, Trippler M, et al. VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res 2007; 138: 291-299.
22. Yamamoto C, Yagi S, Hori T, Iida T, Taniguchi K, Isaji S, Uemoto S. Significance of portal venous VEGF during liver regeneration after hepatectomy. J Surg Res 2010; 159: 4.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
24. Huijun W, Long C, Zhigang Z, Feng J, Muyi G. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis. Exp Mol Pathol 2005; 78: 17-24.
25. Fischer JW, Kinsella MG, Levkau B, Clowes AW, Wight TN. Retroviral overexpression of decorin differentially affects the response of arterial smooth muscle cells to growth factors. Arterioscler Thromb Vasc Biol 2001; 21: 777-784.
26. Droguett R, Cabello-Verrugio C, Riquelme C, Brandan E. Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol 2006; 25: 332-341.
27. Kim MY, Baik SK, Park DH, Jang YO, Suk KT, Yea CJ, et al. Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model. J Gastroenterol 2008; 43: 889-896.
28. Wei HS, Li DG, Lu HM, Zhan YT, Wang ZR, Huang X, et al. Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4). World J Gastroenterol 2000; 6: 540-545.
29. Abshagen K, Eipel C, Kalff JC, Menger MD, Vollmar B. Kupffer cells are mandatory for adequate liver regeneration by mediating hyperperfusion via modulation of vasoactive proteins. Microcirculation 2008; 15: 37-47.
30. Ding BS, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 2010; 468: 310-315.
31. Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 2004; 101: 4477-4482.
32. Kim WH, Matsumoto K, Bessho K, Nakamura T. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 2005; 166: 1017-1028.
33. Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res 2000; 60: 6737-6743.